Brief: Quest Provides Update To Immunotherapy Asset Transfer Between Oncoquest Inc. And Oncoquest Pharmaceuticals Inc.
Feb 2 (Reuters) - Quest Pharmatech Inc QPT.V :
* QUEST PROVIDES UPDATE TO IMMUNOTHERAPY ASSET TRANSFER
BETWEEN
ONCOQUEST INC. AND ONCOQUEST PHARMACEUTICALS INC.
* QUEST PHARMATECH - FINAL PAYMENT OF 65.2 MILLION SHARES OF
OQP
TO ONCOQUEST HAS BEEN DELAYED BEYOND PREVIOUSLY ANTICIPATED
OUTSIDE DATE OF JAN 31, 2021
* QUEST PHARMATECH INC - SHARE ISSUANCE REQUIRES KOREAN
COURT
APPROVAL WHICH HAS BEEN APPLIED FOR BUT NOT YET BEEN RECEIVED
Source text for Eikon: ID:nCNW2Plz8a
Further company coverage: QPT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quest PharmaTech
See all newsBrief: Quest Pharmatech Announces Change Of Chief Executive Officer
Brief: Quest Pharmatech Provides Product Development Update
Brief: Quest PharmaTech Clarifies Agreement in Principle with OQP Bio
Brief: Quest Pharmatech Provides Corporate Update
Brief: Quest PharmaTech Announces Sale Of Bioceltran Investment And Return Of Photodynamic Therapy Technology License